secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEKTAR THERAPEUTICS (NKTR)
CIK:        0000906709
Form:       8-K
Filed at:   2024-12-02T23:59:59+00:00
Accession:  0001213900-24-104240
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nektar completes sale of Huntsville manufacturing facility to Ampersand affiliate
--------------------------------------------------------------------------------

- Closed disposition of Huntsville, AL manufacturing facility and related assets to an affiliate of Ampersand Capital Partners.
- Transaction completed on December 2, 2024, as previously announced on November 4, 2024.
- Purchaser assumed certain related liabilities; no financial terms disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/906709/000121390024104240/0001213900-24-104240-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/906709/000121390024104240/ea0222533-8k_nektar.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-104240

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer